Indivumed Therapeutics

👉 🎞️ Missed joining the #HLSVentureDay 2024 or want to relive the excitement of that wonderful summer day by the Elbe? With the recap video, Life Science Nord brings back the pitches, the conversations, and maybe even a bit of the sunshine! Again, a heartfelt thank you to the organizers, participants, partners, moderators and startups! We are happy to have participated in this event and to be a member of the LSN Network. Additionally, we are grateful for all the synergies that this partnership has already brought and will bring in future. Check out the video, which is in German, but the visuals speak for themselves. 😊 #LSN #Indivumed #Partnership #Biotech #Hamburg

📅➡️ Have you been keeping up with the latest discoveries? We've already had a fantastic year connecting with industry leaders and sharing our insights at some of the most prestigious events in the life science and healthcare sector. 🧬But there is more to come! Continue this journey with us as we head to more key events, ready to unveil our latest research and innovative approaches. 𝗦𝘄𝗶𝗽𝗲 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝘁𝗼 𝘀𝗲𝗲 𝘄𝗵𝗲𝗿𝗲 𝘆𝗼𝘂 𝗰𝗮𝗻 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝘂𝘀 𝗮𝗻𝗱 𝘄𝗵𝗮𝘁 𝘄𝗲'𝗹𝗹 𝗯𝗲 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗶𝗻𝗴 𝗻𝗲𝘅𝘁. #ESMO #BioTechX #BioEurope

𝗪𝗲 𝘄𝗮𝗻𝘁 𝘁𝗼 𝗵𝗲𝗹𝗽 𝗯𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗺𝗼𝘀𝘁 𝗽𝗿𝗲𝗰𝗶𝘀𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘁𝗼 𝗰𝗮𝗻𝗰𝗲𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀. Did you know that this commitment is based on the following principles? 🔹 A proven method to obtain tissue of exceptional quality 🔹 A unique database of in-depth multi-omics and longitudinal clinical data 🔹 A holistic target ID process combining biomathematics and cell biology to reveal novel, disease-relevant targets These result in: 🔹 A decisive boost for our partner‘s R&D pipeline with screening-ready target packages 🔹 A valuable partnership increasing the likelihood of successful drug development Watch the video and see how Indivumed makes a transformative impact on cancer care. 📧 You want to learn more? Feel free to reach out to us anytime – we're always happy to connect with you! Send an E-mail at: [email protected] #precisionmedicine #drugdiscovery #multiomics #cancerresearch #bioinformatics

Have you seen our recent publication showing how multi-omic analysis can unlock the power of personalized medicine for bladder cancer? 🔬 A recent study published in Cell Death Discovery from our Global Clinical Network partners led by Prof. Manuel Smieca and Prof. Gerry Melino from Università di Roma Tor Vergata highlights the power of molecular profiling to guide treatment decisions and improve outcomes. The team carried out multi-omic analysis of tumor tissue taken from a patient with high-grade bladder cancer, collected according to our stringent protocols to prevent loss of sample quality. They found: 🔎 The cancer had an unusually high tumor mutational burden (TMB), together with up-regulation of the PD1, PD-L1 and PD-L2 immune checkpoints.  🔎 Mutations in TP53, TP63, and NOTCH3, providing insights into cancer progression, along with evidence of APOBEC-mediated mutagenesis.  🔎 High hypoxia and proliferation scores compared to other bladder cancers. Taken together, the findings suggest an opportunity for immune checkpoint inhibitor therapy, potentially combined with treatments targeting the p53 pathway and/or tumor hypoxia. This case underlines the importance of molecular profiling to select the most effective personalized therapy for each patient. Read the full paper here: https://lnkd.in/eBNT6pQr #bladdercancer #oncology #PrecisionMedicine #molecularprofiling #multiomics 

🧬 We are #hiring! Are you a dedicated cell biologist eager to make significant strides in precision oncology? 🎯 Join our quest to uncover the molecular intricacies of cancer, with a special focus on addressing unmet therapeutic needs in colon and lung cancer. Our unique tissue library is the starting point for identifying and validating new treatment targets, and your expertise in pharmacological target characterization and screening is vital to our mission. For more details and to apply, please visit https://lnkd.in/e2TDebbw If you have any questions, feel free to leave a comment or send a message directly to Sabine Meinecke, our HR recruiter. #CellBiologyJobs #PharmaceuticalResearch #PrecisionOncology #CancerResearchCareers #JoinOurTeam

Prof. David Gallagher, Oncologist and Geneticist at St James's Hospital Dublin, is a founding member of the Oncology Alliance in 2020. While David is actively involved in cancer research, together with the Oncology Alliance members he supports and values the exchange witihin the collaborative network of Onco AI-Med: "Collaboration is the word of the day in oncology. It's more important now, than it ever has been. We are fortunate to have the collection of experts that we have - an experienced and diverse group that is bringing a lot together." We are proud to have these experts on board and value the collaboration, exchange, and insights to jointly drive precision oncology forward! #cancerresearch #oncology #collaboration

💡Did you know that Indivumed has an external board of well-known oncologists?   The 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗔𝗹𝗹𝗶𝗮𝗻𝗰𝗲 𝗳𝗼𝗿 𝗜𝗻𝗱𝗶𝘃𝗶𝗱𝘂𝗮𝗹𝗶𝘇𝗲𝗱 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 (𝗢𝗻𝗰𝗼 𝗔𝗜-𝗠𝗲𝗱 𝗕𝗼𝗮𝗿𝗱) is an international collaboration founded by us. By bringing together the combined knowledge and experience of oncologists from leading cancer clinics and research institutions world-wide, we advance precision oncology together. Stay tuned as we are more than happy to introduce our Onco AI-Med Board Members in the following weeks!   🎞️ Watch the Onco AI-Med introduction video with John Marshall to learn more about our cooperation: https://lnkd.in/eEpRrKjN #precisionmedicine #cancerresearch #collaboration #precisiononcology

Once again, we were happy to host our tastiest tradition: Sternenbrücke Cake Day! 🧁🍰   With our delicious pastries and cakes, we raised money for Kinder-Hospiz Sternenbrücke.   We are more than happy to continue to support Sternenbrücke Children’s Hospice and thank them for all the work they do!   #sternenbrücke #support #oncology

Last week, Indivumed was invited at the Health & Life Science Venture Day organized by Life Science Nord, an event that brought together investors and innovative ideas from the healthcare sector in Hamburg. 🧬📍 The event featured engaging pitch sessions from established and emerging companies in Medtech, Biotech, and Digital Health, catalyzing opportunities for collaboration and exchange of ideas. Indivumed's VP of Business Development Hans Vanhooren, PhD, had the honor of being a member of the selection committee and moderating a part of the Biotech pitch discussion. Reflecting on the event, Hans shared: "Participating in the #HLSVentureDay offered a great perspective on the innovative efforts within the life sciences sector in Northern Germany. It was inspiring to engage with entrepreneurs and the investor community who are dedicated to advancing the field." A big thank you to Life Science Nord for organizing such an important event! And thanks to FUSE for capturing this event with amazing photos. #HLSVentureDay #LSN #LifeSciences #Innovation #Biotech #Networking #Startups #Hamburg

🎉 Happy Work Anniversary! 🎉 In June five and ten years ago, three incredible colleagues started to work for Indivumed: Ellis, Svenja and Frauke - you make our workplace brighter. Thank you for your contributions to our company, and for five and ten years of dedication, hard work and lots of laughter. We are grateful to celebrate this milestone with you!  #workanniversay #jubilee #thankyou